Key result
Stopping flecainide resolves severe neurotoxicity after 5 days in a reported case.
Why the study?
Severe neurological adverse drug reactions to flecainide have rarely been described.
Case Report (n=1)
Flecainide can cause severe neurological adverse reactions, including myoclonus and severe asthenia, which resolve upon discontinuation.
Answers are grounded in this paper and cite their sources.
Flecainide may cause severe myoclonus and asthenia requiring ICU care; this case extends reports of rare noncardiac toxicities and leaves monitoring open.
Flecainide is class Ic antiarrhythmic drug with a narrow therapeutic range. Adverse drug reactions during flecainide therapy are predominately cardiac in nature. Severe neurological adverse drug reactions have rarely been described. We describe the case of a 71-year-old female who developed myoclonus and severe asthenia requiring intubation and management in the neuroscience intensive care unit. Immediate discontinuation of flecainide and supportive care to allow for drug elimination was the primary treatment. Resolution of flecainide neurotoxicity resolved after 5 days of stopping flecainide. Clinicians should be cognizant of potential neurologic toxicity of flecainide.
No takes yet. Share an insight, caveat, or question.
Shewmaker et al. (2026) conducted a case report in Flecainide neurotoxicity (n=1). Flecainide was evaluated on Resolution of flecainide neurotoxicity. Discontinuation of flecainide and supportive care led to the resolution of severe neurotoxicity (myoclonus and asthenia) after 5 days in a 71-year-old female.
Synapse has enriched 10 related papers. Consider them for comparative context: